116 drug patents listed in Korea’s green list in May

Published: 2013-06-03 06:58:00

Updated: 2013-06-03 06:58:00

The Ministry of Food and Drug Safety (MFDS) said Thursday that 116 medicinal products (most of foreign drugs except Handok Pharm’s Soliris and Aggrastat and Hyundai Pharm’s Zindaclin) were newly included into green list in May, which can be compared to the "Orange Book" in the U.S.

The MFDS sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK